Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHUK | O15111 | 7/20 | 1.00 |
| ▸ | GABRA1 | P14867 | 2/20 | 1.00 |
| ▸ | GABRG2 | P18507 | 2/20 | 1.00 |
| ▸ | GABRB3 | P28472 | 2/20 | 1.00 |
| ▸ | GABRA5 | P31644 | 2/20 | 1.00 |
| ▸ | GABRA3 | P34903 | 2/20 | 1.00 |
| ▸ | GABRA2 | P47869 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | GABRP | O00591 | 1/20 | 1.00 |
| ▸ | GABRD | O14764 | 1/20 | 1.00 |
| ▸ | IKBKB | O14920 | 1/20 | 1.00 |
| ▸ | AURKA | O14965 | 1/20 | 1.00 |
| ▸ | PIM1 | P11309 | 1/20 | 1.00 |
| ▸ | TOP1 | P11387 | 1/20 | 1.00 |
| ▸ | IDO1 | P14902 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | GABRB1 | P18505 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norharmane SCHEMBL29370219 | 1.00 | CHUK (1.00) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL9486853 | 1.00 | CHUK (1.00) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Carbazole SCHEMBL18684843 | 1.00 | CHUK (1.00) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL11561251 | 0.98 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL21378153 | 0.98 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL8683826 | 0.98 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL30013210 | 0.98 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL8686167 | 0.98 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL29809643 | 0.98 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL29217000 | 0.98 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13950 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431371-B | Beta-carbolin 3,6, 9-modified derivative and preparation method and application thereof | 沈阳药科大学 | 2026-05-19 | — | — | CN | claimed |
| CN-117186133-B | Carboline-fluorobopyrrole photosensitizer and preparation and application thereof in resisting breast cancer | 浙江大学 | 2026-05-19 | — | — | CN | claimed |
| CN-119688896-B | Cell membrane bionic nano-recognition material and preparation method and application thereof | 陕西科技大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4716472-A1 | POUCHED PRODUCT AND METHOD OF MAKING | Imperial Tobacco Limited (GB) | 2026-04-01 | — | — | EP | claimed |
| US-20250360150-A1 | METHODS OF USING NEUROPLASTIC AGENTS AND TERRAFORMING MARS | BRANNOCK METCALF MOLLY CAROLINE (US) | 2025-11-27 | — | — | US | claimed |
| EP-4646432-A1 | ANTI-IL-18BP ANTIBODIES | Lassen Therapeutics, Inc. (US) | 2025-11-12 | — | — | EP | claimed |
| EP-4646433-A1 | ANTI-IL-18BP ANTIBODIES | Lassen Therapeutics, Inc. (US) | 2025-11-12 | — | — | EP | claimed |
| EP-4633638-A1 | TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) | Luminous Mind Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| US-20250281399-A1 | A MUCOADHESIVE FILM COMPRISING A PHARMACEUTICALLY ACTIVE AGENT AND USES THEREOF | SHORT WAVE PHARMA INC. (CA) | 2025-09-11 | — | — | US | claimed |
| US-20250188170-A1 | COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2b ANTIBODIES | ATYR PHARMA, INC. | 2025-06-12 | — | — | US | claimed |
| US-4644062-A | WITH TERT-BUTYL HYPOCHLORITE AND TERTIARY AMINE | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-02-17 | — | — | US | claimed |
| US-4623649-A | PSYCHOPHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-11-18 | — | — | US | claimed |
| EP-0039804-B1 | CYCLIC AMIDES | USV PHARMACEUTICAL CORPORATION (US) | 1986-08-20 | — | — | EP | claimed |
| US-4600715-A | CENTRAL NERVOUS SYSTEM | SHERING AKTIENGESELLSCHAFT (DE) | 1986-07-15 | — | — | US | claimed |
| US-4596808-A | Nervous system disorders | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-06-24 | — | — | US | claimed |
| EP-0059817-B1 | SERPENTINE, ALSTONINE AND SEMPERVIRINE DRUGS FOR THE SPECIFIC INHIBITION OF TUMUROUS AND CANCEROUS CELLS | Beljanski, Mirko (FR) | 1985-10-09 | — | — | EP | claimed |
| EP-0110813-A2 | Process for producing beta-carboline derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-06-13 | — | — | EP | claimed |
| US-4435403-A | TRANQUILIZERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-03-06 | — | — | US | claimed |
| EP-0059817-A1 | Serpentine, alstonine and sempervirine drugs for the specific inhibition of tumurous and cancerous cells | Beljanski, Mirko (FR) | 1982-09-15 | — | — | EP | claimed |
| EP-0054507-A2 | 3-Substituted beta-carbolines, process for their production and compositions containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-06-23 | — | — | EP | claimed |